Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy

Francesca Saluzzo(IRCCS Ospedale San Raffaele), Daniela María Cirillo(Vita-Salute San Raffaele University), Patrizia Paola Erba(Vita-Salute San Raffaele University), Federica Cugnata(Vita-Salute San Raffaele University), Cristina Tresoldi(Vita-Salute San Raffaele University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Patrizia Rovere‐Querini(Vita-Salute San Raffaele University), Marta Cilla(Vita-Salute San Raffaele University), Sara Racca(IRCCS Ospedale San Raffaele), Paola Mantegani(IRCCS Ospedale San Raffaele), Clelia Di Serio(Vita-Salute San Raffaele University), Valeria Poletti de Chaurand(Azienda Ospedaliera San Gerardo)
European Respiratory Journal
October 14, 2021
10.1183/13993003.02099-2021
Cited by 5

Related Papers

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
|The Lancet Microbe|2022|304
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
|The Lancet|2022|286
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
|Critical Care and Resuscitation|2020|229